|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0366 USD | -2.27% |
|
0.00% | +46.40% |
| Capitalization | 519K 450K 424K 385K 713K 44.95M 803K 5.02M 1.92M 20.59M 1.95M 1.91M 75.69M | P/E ratio 2022 |
-0.11x | P/E ratio 2023 | -0.31x |
|---|---|---|---|---|---|
| Enterprise value | 22.05M 19.12M 18.01M 16.37M 30.28M 1.91B 34.12M 213M 81.64M 875M 82.73M 80.97M 3.22B | EV / Sales 2022 |
11.6x | EV / Sales 2023 | 10.1x |
| Free-Float |
51.2% | Yield 2022 * |
-
| Yield 2023 | - |
More valuation ratios
* Estimated data
More news
More press releases
| 1 day | -2.27% | ||
| Current month | -2.14% | ||
| 3 months | -25.31% | ||
| 6 months | -40.00% | ||
| Current year | +46.40% |
| 1 month | 0.04 |  | 0.04 |
| Current year | 0.03 | | 0.06 |
| 1 year | 0.02 | | 0.16 |
| 3 years | 0.02 | | 0.62 |
| 5 years | 0.02 | | 5.57 |
| 10 years | 0.02 | | 5.57 |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie Buttorff
CEO | Chief Executive Officer | 68 | 2021-06-29 |
Nick Cavarra
PSD | President | - | - |
| Chief Tech/Sci/R&D Officer | 60 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Leslie Buttorff
CHM | Chairman | 68 | 2021-06-29 |
Lawrence Wert
BRD | Director/Board Member | 67 | 2020-04-28 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.27% | 0.00% | -78.34% | -90.61% | 777K | ||
| -2.84% | -6.91% | -13.71% | +156.52% | 685B | ||
| -0.62% | -4.65% | +0.70% | -13.42% | 360B | ||
| -0.10% | -3.02% | +8.75% | +29.16% | 327B | ||
| -2.58% | -7.83% | -51.84% | +25.00% | 326B | ||
| -0.27% | -3.86% | +2.57% | -13.95% | 255B | ||
| -0.34% | -2.34% | +0.96% | +20.36% | 228B | ||
| -1.52% | -5.41% | -16.68% | +2.61% | 217B | ||
| -0.29% | -3.24% | -39.52% | -10.19% | 199B | ||
| -0.10% | -2.00% | -6.11% | +21.36% | 156B | ||
| Average | -1.09% | -3.75% | -19.32% | +12.68% | 275.2B | |
| Weighted average by Cap. | -1.31% | -4.71% | -12.62% | +44.69% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.63M 1.41M 1.33M 1.21M 2.23M 141M 2.52M 15.74M 6.02M 64.55M 6.1M 5.97M 237M | 2.38M 2.07M 1.95M 1.77M 3.28M 207M 3.69M 23.08M 8.83M 94.63M 8.95M 8.76M 348M |
| Net income | -9.14M -7.93M -7.47M -6.79M -12.56M -792M -14.15M -88.46M -33.85M -363M -34.31M -33.58M -1.33B | -8.02M -6.95M -6.55M -5.95M -11.01M -694M -12.4M -77.55M -29.68M -318M -30.08M -29.44M -1.17B |
| Net Debt | 17.85M 15.49M 14.59M 13.25M 24.52M 1.55B 27.63M 173M 66.11M 708M 66.99M 65.57M 2.6B | 21.53M 18.67M 17.59M 15.98M 29.57M 1.86B 33.32M 208M 79.72M 854M 80.79M 79.06M 3.14B |
More financial data
* Estimated data
Employees
40
Sector
Pharmaceuticals
- Stock Market
- Equities
- PLSH Stock
Select your edition
All financial news and data tailored to specific country editions
